Transfusion requirements in acute coronary syndrome patients undergoing thrombolysis or anticoagulation: A retrospective cohort study.
Аннотация
Bleeding complications and associated transfusion requirements remain a significant concern in patients with Acute Coronary Syndrome (ACS) undergoing anticoagulation or thrombolysis, yet data on transfusion needs and risk factors in resource-limited settings are limited. Therefore, it is of interest to assess transfusion requirements in 85 patients with Acute Coronary Syndrome (ACS) undergoing anticoagulation or thrombolysis at UPUMS, Saifai, from December 2024 to April 2025. Major bleeding requiring transfusion occurred in 4.7% (n=4) of patients, predominantly due to gastrointestinal sources (50%). The mean transfusion requirement was 2 units of packed red blood cells per bleeding event. Independent risk factors for major bleeding were age >65 years, chronic kidney disease and triple therapy (antiplatelet + anticoagulant + fibrinolytic). Bleeding was associated with significantly higher 30-day mortality (25% versus 5% in non-bleeders), highlighting the need for individualized antithrombotic strategies in ACS management.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.